ACTIVITY TITLE
COVID-19 Vaccine Delivery and Health System Strengthening in Africa
Livraison de vaccins contre la COVID-19 et renforcement des systèmes de santé en Afrique
Reported by
| ACTIVITY SCOPE | COLLABORATION TYPE | AID TYPE | FINANCE TYPE | FLOW TYPE | TIED STATUS | HIERARCHY |
|---|---|---|---|---|---|---|
| Bilateral 1 |
Contributions to specific-purpose programmes and funds managed by implementing partners B03
|
Standard grant 110 | 1 |
DOCUMENTS ( 5 )
Description
TEXT/HTML
EN
Objectives / Purpose of activity
Results, outcomes and outputs
Description
TEXT/HTML
FR
Objectives / Purpose of activity
Results, outcomes and outputs
Proactive disclosure
TEXT/HTML
EN
Summary information about contract
Divulgation proactive
TEXT/HTML
FR
Summary information about contract
Activity website
TEXT/HTML
EN
Activity web page
Planned end date 2024-11-30
Actual start date 2022-12-23
Actual end date 2024-12-31
activity status: Finalisation
Physical activity is complete or the final disbursement has been made, but the activity remains open pending financial sign off or M&E
WHO'S INVOLVED ( 3 )
| PARTICIPATING ORG | REFERENCE | ROLE | TYPE |
|---|---|---|---|
Affaires étrangères, Commerce et Développement Canada Foreign Affairs, Trade and Development Canada
|
REF CA-3
|
Extending | Government |
Canada Canada
|
REF CA
|
Funding | Government |
WHO - World Health Organization WHO - World Health Organization
|
REF XM-DAC-41143
CRS World Health Organisation - core voluntary contributions account
|
Implementing | Multilateral |
General
Ce projet vise à rendre plus équitable l’accès aux vaccins contre la COVID-19, plus particulièrement parmi les groupes prioritaires et les populations vulnérables. Le projet cherche également à renforcer les systèmes de santé grâce à l’amélioration de la distribution des vaccins, à la sensibilisation des collectivités, à la mise en place de systèmes de données, et à la fourniture de services de vaccination et de soins de santé primaires équitables entre les sexes dans sept pays cibles d’Afrique. Le projet soutient également l’intervention d’urgence à l’urgence de santé publique de portée internationale (USPPI) liée à la variole du singe en République démocratique du Congo (RDC). Les activités du projet comptent parmi les suivantes : (1) prestation d’un appui technique pour la mise en œuvre et le suivi des programmes de vaccination, en particulier les composantes sensibles au genre; (2) élaboration de stratégies et de plans de vaccination englobant des interventions sensibles au genre; et (3) déploiement d’équipes mobiles pour vacciner les groupes prioritaires.
This project aims to increase equitable access to COVID-19 vaccines, particularly among priority groups and vulnerable populations. It also seeks to reinforce health systems through strengthened vaccine delivery, community outreach, data systems, and the delivery of gender-equitable immunization and primary health care in seven target countries in Africa. The project also supports emergency response to the mpox Public Health Emergency of International Concern (PHEIC) in the Democratic of the Congo (DRC). Project activities include: (1) providing technical support for the implementation and monitoring of vaccination programmes, particularly gender-responsive components; (2) developing vaccination strategies and plans with gender-responsive interventions; and (3) deploying mobile teams to vaccinate priority groups.
policy marker( 1 )
| CODELIST | SIGNIFICANCE | VOCABULARY | DESCRIPTION |
|---|---|---|---|
| Gender Equality | significant objective | OECD DAC CRS | Significant (secondary) policy objectives are those which, although important, were not the prime motivation for undertaking the activity. |
recipient country ( 10 )
GhanaGH
MalawiMW
MozambiqueMZ
CameroonCM
Gambia (the)GM
SenegalSN
Côte d'IvoireCI
Congo (the Democratic Republic of the)CD
NigeriaNG
Tanzania, the United Republic ofTZ
recipient region ( 1 )
OECD DAC ( 1 )
Supra-national regions according to OECD DAC CRS recipient codes http://reference.iatistandard.org/codelists/Region/
Africa, regional298
sector ( 2 )
OECD DAC CRS 5 digit1( 2 )
The sector reported corresponds to an OECD DAC CRS 5-digit purpose code http://reference.iatistandard.org/codelists/Sector/
COVID-19 control12264
Infectious disease control12250
GLOSSARY
COVID-19 controlAll activities related to COVID-19 control e.g. information, education and communication; testing; prevention; immunisation, treatment, care.
Infectious disease controlImmunisation; prevention and control of infectious and parasite diseases, except malaria (12262), tuberculosis (12263), COVID-19 (12264), HIV/AIDS and other STDs (13040). It includes diarrheal diseases, vector-borne diseases (e.g. river blindness and guinea worm), viral diseases, mycosis, helminthiasis, zoonosis, diseases by other bacteria and viruses, pediculosis, etc.
Financial Overview
Outgoing Commitment ( 1 )
Disbursement ( 1 )
Budget ( 1 )
Outgoing Commitment
Disbursement
Budget
Budget ( 1 )
| START | END | TYPE | STATUS | VALUE |
|---|---|---|---|---|
| 2022-04-01 | 2023-03-31 | Original | Committed | 27,000,000 CAD |
Budget
Transactions ( 2 )
Outgoing Commitment ( 1 )
| DATE | DESCRIPTION | PROVIDER | RECEIVER | VALUE |
|---|---|---|---|---|
| 2022-12-23 |
FLOW ODA
10
STATUS Untied 5
|
27,000,000 CAD |
Outgoing Commitment
Disbursement ( 1 )
| DATE | DESCRIPTION | PROVIDER | RECEIVER | VALUE |
|---|---|---|---|---|
| 2022-12-22 |
FLOW ODA
10
|
REF XM-DAC-41143
|
27,000,000 CAD |
Disbursement
result( 2 )
outcome( 2 )
GLOSSARY
OutcomeResults of the activity that produce an effect on the overall communities or issues you serve. For example lower rate of infection after a vaccination programme.
Outcome
indicator( 1 )
Expected Results
Résultats escomptés
INDICATOR
Results expected
Résultats escomptés
Les résultats attendus de ce projet comptent parmi les suivants : (1) augmentation des taux de vaccination contre la COVID-19 parmi les groupes hautement prioritaires dans sept pays; (2) renforcement des systèmes de santé dans sept pays, afin de distribuer et d’administrer efficacement les vaccins contre la COVID-19; et (3) élaboration de stratégies de vaccination adaptées au sexe.
The expected outcomes for this project include: (1) increased COVID-19 vaccination rates among high-priority groups in seven countries. (2) strengthened health systems in seven countries to successfully distribute and deliver COVID-19 vaccines; and (3) developed gender-responsive immunization strategies.
| FACET | BASELINE | TARGET | ACTUAL | % | PERIOD |
|---|---|---|---|---|---|
| Qualitative | Qualitative |
Outcome
indicator( 1 )
Results achieved
Résultats atteints
INDICATOR
Results achieved
Résultats atteints
Les résultats obtenus à la fin du projet (décembre 2024) comprennent : 1) une augmentation de la couverture de la série primaire de vaccination contre la COVID-19 de 28,1 % en février 2023 à 33,1 % dans les pays cibles; 2) l'élaboration d’une microplanification au niveau infranational et intégration du traitement de la COVID-19 dans d’autres services de routine, notamment les cliniques pour les patients atteints du VIH, de la tuberculose, du cancer, du diabète et de maladies cardiovasculaires; 3) la vaccination de 29 millions de personnes supplémentaires avec au moins une dose de vaccin contre la COVID-19, dont 27 millions ont terminé la série primaire du vaccin, grâce à de stratégies adaptées au sexe; 4) la facilitation de la formation de 160 membres du personnel de la santé à la surveillance et au traitement clinique de la maladie, et la prestation d’une aide à l’amélioration des systèmes de surveillance et de données. Ce qui a permis de porter de 60 % à 83 % les taux de recherche des contacts pour la variole du singe en RDC.
Results achieved at the end of the project (December 2024) include: (1) increased COVID-19 vaccination coverage for the primary series from 28.1% in February 2023 to 33.1% in target countries; (2) developed microplanning at sub-national levels and integrated COVID-19 into other routine services, including clinics for patients living with human immunodeficiency virus, tuberculosis, cancer, diabetes, and cardiovascular diseases; (3) vaccinated an additional 29 million individuals with at least 1 COVID-19 dose. 27 million of them completed the primary series, using gender-responsive strategies; and (4) facilitated training on disease surveillance and clinical management for 160 health staff and helped to enhance surveillance and data systems. This enabled contact tracing rates for monkeypox in the DRC to rise from 60% to 83%.
| FACET | BASELINE | TARGET | ACTUAL | % | PERIOD |
|---|---|---|---|---|---|
| Qualitative | Qualitative |
General Enquiries
Affaires étrangères, Commerce et Développement Canada (MAECD)
Foreign Affairs, Trade and Development Canada (DFATD)
125 Sussex Drive, Ottawa, Ontario, K1A 0G2
125, promenade Sussex, Ottawa (Ontario), K1A 0G2
related activity( 1 )
experimental! view network
| REFERENCE IDENTIFIER | TYPE | DESCRIPTION |
|---|---|---|
| CA-3-P011860001 | Sibling | A sub-activity (or sub-component) that is related to another sub-activity with the same parent |
other identifier( 1 )
| REFERENCE IDENTIFIER | OWNER ORG IDENTIFIER | TYPE | DESCRIPTION |
|---|---|---|---|
| 2022200921 |
CRS Activity identifier
CODE A2
|
No description provided |